BAXALTA BIOSCIENCE INDIA PRIVATE LIMITED

Corporate

Takeda Neuroscience Is Driven By The Unmet Need Of Patients With Neurologic And Psychiatric Diseases. Our Mission Is To Bring Innovative And Potentially Disease-Modifying Medicines To These Individuals. Our Dedication Extends Beyond Our Marketed Products And Research Efforts. We Are Committed To Raising Awareness For These Conditions, Building Strategic Partnerships With Both Industry And Advocacy, Educating Patients And Physicians, And Broadening Access To Therapies. Disease Areas*: Major Depressive Disorder (Mdd): Mdd, Commonly Known As Depression, Is A Complex Mental Health Illness That Is Among The Leading Causes Of Disability Worldwide.1,2 Mdd Often Can Often Include Having Five Or More Symptoms Of Depression In The Same Two-Week Period.1 At Least One Of The Symptoms Must Be Either Depressed Mood Or Loss Of Interest Or Pleasure; Examples Of Other Possible Symptoms May Include Significant Change In Weight Or Appetite, Insomnia Or Excessive Sleepiness, Loss Of Energy, And Feelings Of Worthlessness Or Guilt, Among Others.1 Attention-Deficit Hyperactivity Disorder (Adhd): Adhd Is A Neurodevelopmental Disorder Characterized By A Repeated Pattern Of Inattention And/Or Hyperactivity/Impulsivity That Interferes With Functioning Or Development.1 Adhd Often Persists From Childhood Into Adulthood And May Manifest Differently Throughout The Lifespan.

For More Than 70 Years, Takeda Has Supplied Vaccines To Protect The Health Of People In Japan. Today, Takeda’S Global Vaccine Business Is Applying Innovation To Tackle Some Of The World’S Most Challenging Infectious Diseases, Such As Dengue, Covid-19, Pandemic Influenza And Zika. Takeda’S Team Brings An Outstanding Track Record And A Wealth Of Knowledge In Vaccine Development And Manufacturing To Advance A Pipeline Of Vaccines To Address Some Of The World’S Most Pressing Public Health Needs.

Our R&D Center For External Innovation (Cei) Is An Integrated Team Driving Innovation From Target Identification Through Clinical Development And Commercialization. Within Cei, Our Unique Model Supports Diverse And Flexible Partnerships Around The World To Harness Innovation Across The Discovery And Development Lifecycle.

We Recognize That Many Scientific Challenges We Face Are Too Large And Complex For Any One Organization To Tackle By Itself. We Are Stronger When We Work Precompetitively And Collaborate To Advance Our R&D Efforts More Efficiently And Effectively To Deliver Transformative Medicines To Patients.

We Are Committed To Integrity And Transparency As We Carry Out Clinical Research. Our Dedicated Clinical Trial Website Serves As A Resource For Patients, Medical Professionals, Researchers And Others Interested In Learning About Past And Ongoing Clinical Trials.